Sector

Healthcare

One of the most prominent practices in Europe, on a growing resilient sector, underpinned by constant innovation in biotech and medtech, and long-term demand for healthcare services.

Bryan, Garnier & Co's insights and news

Read the latest news, reports and newsletters from Europe’s Growth Investment Bank to find out more about current trends impacting investment banking activity and company performance.

Healthcare transactions

Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.

Bryan, Garnier & Co advised Groupe Novasep on its divestiture of TangenX

TangenX_website_tombstone

New challenger in spinal implants : Bryan, Garnier & Co advises Spineart on €30M Equity Investment from Gimv

Spineart tombstone

Bryan, Garnier & Co announces the successful USD 22 million / DKK 143 million follow-on offering for Zealand Pharma

Zealand tombstone

Bryan, Garnier & Co advised Briggs Healthcare in acquisition of SimpleLTC

Briggshealthcare_website_tombstone

Bryan, Garnier & Co announces the successful €18m Private Placement of Nicox

Nicox tombstone

Bryan Garnier & Co advises GeNeuro on its Euronext IPO, raising €33 million, acting as Global Coordinator & Joint Bookrunner

GeNeuro tombstone

Capital Raise Florealis

Florealis_tombstone_feb16

Bryan, Garnier & Co announces the successful €25m Placement of Erytech

Erytech tombstone

Bryan Garnier & Co advises DBV Technologies on its follow-on offering, raising $281.5m in July 2015, acting as financial advisor

DBV Technologies tombstone

Bryan, Garnier & Co announces the successful $100m Nasdaq IPO of Celyad.

Celyad 2015 tombstone

Bryan, Garnier & Co announces that the total proceeds of Galapagos IPO on Nasdaq, the largest Nasdaq IPO of a European biotech, have been raised to $317m following the full exercise of over-allotment option.

Galapagos tombstone

Bryan, Garnier & Co announces the successful follow-on offering of £20m for Advanced Oncotherapy plc

Advanced Oncotherapy tombstone

Bryan, Garnier & Co acts as Placement Agent for Nicox €27m Private Placement (PIPE)

Nicox 2015 tombstone

Bryan, Garnier & Co acts as Placement Agent for Cardio3 BioScience’s €32m Capital Raise

Cardio3 tombstone

Bryan, Garnier & Co announces the successful IPO of Bone Therapeutics.

Bone Therapeutics 2015 tombstone

Bryan, Garnier & Co announces the IPO of Quantum Pharma on London AIM

Quantum Pharma tombstone

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }